About: Tolerability of methotrexate starting with 15 or 25 mg/week for rheumatoid arthritis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Tolerability of methotrexate starting with 15 or 25 mg/week for rheumatoid arthritis Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 1994

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в січні 1994 (uk) im Jahr 1994 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xineru de 1994 (ast) artikull shkencor i botuar më 01 janar 1994 (sq) scientific article published on 01 January 1994 (en)
publication date	wds:Q72750229-8EB62976-8BB3-4B87-9257-BFB5D2BBF618
publication date	1994-01-01 00:00:00Z (xsd:dateTime)
exact match	wds:Q72750229-BADDB9EE-6841-4C2C-A209-BA347F09D127
exact match	https://scigraph.springernature.com/pub.10.1007/bf00302669
cites work	wds:Q72750229-0189F871-6392-4553-A297-EB8CBB9B7E6E wds:Q72750229-020C0909-F8F3-49B8-9E83-67B7E19CDB8B wds:Q72750229-11B1637D-9AE1-46D2-B1D9-6A7CC31EAE3E wds:Q72750229-17F86CE8-C1B6-4E23-B465-2570DD5F200D wds:Q72750229-1C222F8E-2996-404F-8C37-CBA98BC354DC wds:Q72750229-35E97EEE-2948-45C3-9256-818EF61C4AAF wds:Q72750229-38DAD4D7-622F-4D36-BC9A-1C7CC0FF0505 wds:Q72750229-4359BD52-A8D3-445E-A2C0-C25DB5499776 wds:Q72750229-444186F3-DC85-4DF5-B64A-6AE714773016 wds:Q72750229-47BF12D4-362F-4E93-940D-74D83B44220C wds:Q72750229-6793BB1D-5B44-4AC5-8E70-D49DFC262A70 wds:Q72750229-778E7DE8-3050-4EA7-977F-C46B9A0B5593 wds:Q72750229-79BBD1E4-9B0A-4825-8433-220175ADF2FE wds:Q72750229-974382ED-88D9-4407-8B83-C3049030BE72 wds:Q72750229-9A2E2D9C-764A-45BE-804A-0BEE686EE734 wds:Q72750229-9EA4AFB5-A50C-4ECB-AC5F-E2A4EE7D21DE wds:Q72750229-A2D594CF-5E01-4ACB-9504-3EBB171064B7 wds:Q72750229-AA0FAD33-3681-4D32-92F3-72C1C6D70F15 wds:Q72750229-BEEB65E3-70AE-46C1-8733-7A23735083C3 wds:Q72750229-C2778350-2992-4E03-94F7-5C1CB46DE1BE wds:Q72750229-C3AB25C8-226E-4F12-9EC7-EC0AF9E6A08B wds:Q72750229-C4CC58BB-4533-4D38-B88E-12DAB696382C wds:Q72750229-D889F157-3ED6-4F6A-92A0-1F26DAF018CF wds:Q72750229-DB06FFC5-4F02-4F81-BEA7-DABDFB345ED4 wds:Q72750229-DD87E895-9106-4249-9281-943AC1EF070F wds:Q72750229-DDA270E9-D5E8-4032-912F-21ECF3BDCE62 wds:Q72750229-EDA0CF87-7C15-4964-B38B-FF100CA151F8 wds:Q72750229-F029299D-F8FC-492C-BD3B-FD0A064D5B4E wds:Q72750229-F2666D5B-158C-448C-9D2D-ED447A63288A wds:Q72750229-FED3CF60-6EC3-4C54-A001-171B761FD316
cites work	Methotrexate pneumonitis in rheumatoid arthritis: potential risk factors. Four case reports and a review of the literature Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices: II. Second line drugs and prednisone Liver histology in rheumatoid arthritis patients receiving long-term methotrexate therapy. A prospective study with baseline and sequential biopsy samples Histopathologic findings in the liver of rheumatoid arthritis patients treated with long-term bolus methotrexate Liver biopsy findings in patients with rheumatoid arthritis undergoing longterm treatment with methotrexate. Long-term experience with low dose methotrexate in rheumatoid arthritis Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14-year prospective evaluation of 1017 consecutive starts The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis Treatment of rheumatoid arthritis with methotrexate: a prospective open longterm study of 191 cases Life table analysis of 879 treatment episodes with slow acting antirheumatic drugs in community rheumatology practice Prospective long term follow-up of methotrexate therapy in rheumatoid arthritis: toxicity, efficacy and radiological progression Efficacy of low-dose methotrexate in rheumatoid arthritis Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial Retardation of radiologic progression in rheumatoid arthritis with methotrexate therapy. A controlled study Low-dose methotrexate compared with auranofin in adult rheumatoid arthritis. A thirty-six-week, double-blind trial Methotrexate versus azathioprine in the treatment of rheumatoid arthritis. A forty-eight–week randomized, double-blind trial Increasing methotrexate effect with increasing dose in the treatment of resistant rheumatoid arthritis. Influence of methotrexate and azathioprine on radiologic progression in rheumatoid arthritis. A randomized, double-blind study The effects of drug therapy on radiographic progression of rheumatoid arthritis. Results of a 36-week randomized trial comparing methotrexate and auranofin Weekly pulse methotrexate in rheumatoid arthritis. Clinical and immunologic effects in a randomized, double-blind study. Toxicity of methotrexate compared with azathioprine in the treatment of rheumatoid arthritis. A case-control study of 131 patients Comparison of azathioprine, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial Comparison of auranofin, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial Methotrexate therapy in rheumatoid arthritis: a life table review of 587 patients treated in community practice. Pneumonitis complicating low-dose methotrexate therapy in rheumatoid arthritis Acute lung disease associated with low-dose pulse methotrexate therapy in patients with rheumatoid arthritis A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis The efficacy and toxicity of a constant low dose of methotrexate as a treatment for intractable rheumatoid arthritis: an open prospective study A prospective analysis of liver biopsies in rheumatoid arthritis patients receiving long term methotrexate therapy Treatment of rheumatoid arthritis with higher dose intravenous methotrexate.
author name string	wds:Q72750229-A1EC703B-8AE5-4DD4-91B5-97701362933A wds:Q72750229-B9A6EFAD-CFA7-4DFE-8B1D-78BC1231DDF5 wds:Q72750229-C0470E9F-3A66-42FE-95CC-D3A9E86B9609 wds:Q72750229-D662FB73-62C9-411D-AB9D-A0493E2D6CCE
author name string	W L Gross E Reinhold-Keller A Schnabel V Willmann
rdfs:label	Tolerability of methotrexate starting with 15 or 25 mg/week for rheumatoid arthritis (en) Tolerability of methotrexate starting with 15 or 25 mg/week for rheumatoid arthritis (nl) Tolerability of methotrexate starting with 15 or 25 mg/week for rheumatoid arthritis (sq)
skos:prefLabel	Tolerability of methotrexate starting with 15 or 25 mg/week for rheumatoid arthritis (en) Tolerability of methotrexate starting with 15 or 25 mg/week for rheumatoid arthritis (nl) Tolerability of methotrexate starting with 15 or 25 mg/week for rheumatoid arthritis (sq)
name	Tolerability of methotrexate starting with 15 or 25 mg/week for rheumatoid arthritis (en) Tolerability of methotrexate starting with 15 or 25 mg/week for rheumatoid arthritis (nl) Tolerability of methotrexate starting with 15 or 25 mg/week for rheumatoid arthritis (sq)
title	wds:Q72750229-94569214-1E99-4850-9AF5-839860685219
title	Tolerability of methotrexate starting with 15 or 25 mg/week for rheumatoid arthritis (en)
page(s)	wds:Q72750229-03007C2C-015D-4023-ADD3-F5449C2A57EC
page(s)	33-38
instance of	wds:Q72750229-6A29C4AF-2604-4B16-B134-839AB169D20D
instance of	scholarly article
main subject	wds:Q72750229-3AEA314B-25EF-46A0-8F13-BAFC56678453 wds:Q72750229-8B87BC88-8EB1-49EA-A27E-7985078188C5
main subject	rheumatoid arthritis wd:Q422232
PubMed ID	wds:Q72750229-7204ECF5-6E91-4E97-921B-2C9C2698BF43
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7939138

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software